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Background
In-vivo carotid CMR is able to identify features of plaque
vulnerability such as lipid core size. However, the current
standard (multicontrast CMR) requires contrast media,
extensive post-processing and subjective interpretation.
Recently we proposed to use quantitative T2 mapping to
distinguish plaque lipid from surrounding fibrous tissue
and measure lipid core size. This study aimed to (1) vali-
date plaque lipid quantification by T2 mapping against
histology and (2) investigate if it could discriminate
between symptomatic and asymptomatic patients.
Methods
CMR
40 patients scheduled for carotid endarterectomy (50-
99% stenosis on Ultrasound), either symptomatic or
asymptomatic, were imaged at 3T (Siemens Verio) max
24 h before surgery (IRB approved, written consent
obtained). We used our novel black-blood Multiecho
Spin-Echo sequence for T2 mapping (DANTE-MESE) to
acquire 5 slices in 4 min (TR = 2 s, TE = 9-18-…-126
ms, partial Fourier = 5/8, FOV = 128 × 128 mm, matrix
size = 384 × 384, slice thickness = 2 mm, slice gap = 2
mm). T2 maps were generated using nonlinear fitting;
lumen and external carotid boundary were contoured
semi-automatically; lipid core was segmented from other
plaque components by T2 thresholding; and the optimal
segmentation (i.e. highest correlation with histology)
was automatically calculated using leave-one-out cross-
validation (Figure 1).
Histology
Plaques were collected at the time of carotid endarterect-
omy, processed and cut at 1 mm intervals using carotid
bifurcation and T1w images as references to match T2
map locations. Plaque lipid area was manually segmented
on sections stained with H&E and Masson Trichrome,
with Oil-red-O used to confirm lipid distribution.
Results
26 patient scans (median age 69) had good quality and
60 slices with matching locations on plaque histology.
Lipid without haemorrhage had shorter T2 than normal
vessel wall and fibrous tissue, whereas haemorrhage
infiltrating the lipid core increased T2. Thresholding
T2 < 42 ms and T2 > 90 ms resulted in the globally
optimal lipid core segmentation (highest R = 0.85 with
histology, Figure 2A). We found significantly more lipid
in symptomatic than in asymptomatic plaques (Figure
2B); ROC analysis showed a fair/good ability to discrimi-
nate between the 2 groups; and the optimal cut-off value
~25% agreed with histological studies that found higher
risk of rupture associated with lipid core >25% of plaque
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Figure 1 Acquisition and analysis pipeline for plaque lipid quantification. I) Time-of-Flight (TOF) bright-blood images were acquired to
localize carotid bifurcation and stenosis. II) Multiple T2 map slices were acquired using our novel DANTE-MESE sequence that combines black-
blood preparation based on non-selective DANTE pulse trains with Multiecho Spin-Echo. T2 maps were generated using nonlinear fitting; lumen
and external carotid boundary were contoured semi-automatically; on T2 maps plaque calcification is shown in black, lipid in blue, normal vessel
wall and fibrous tissue in light blue/green, and intraplaque haemorrhage in yellow/red. III) Plaque lipid area was automatically segmented on
carotid T2 maps using leave-one-out cross-validation. IV) Plaque lipid area was manually segmented (blinded to T2 maps) on matching
histological sections stained with H&E and Masson Trichrome, with Oil-red-O used to confirm lipid distribution.
Figure 2 Histological validation and clinical results. A) The highest correlation (R = 0.85, P < 0.001) between plaque lipid area (%) measured
on T2 maps and on histology was achieved by the thresholding combination T2 < 42 ms and T2 > 90 ms (using leave-one-out cross-validation).
B) Symptomatic plaques contained significant more lipid than asymptomatic plaques (31.5 ± 3.7% vs. 15.8 ± 3.1%, P = 0.005) despite similar
degree of luminal stenosis (15 symptomatic patients, median age 73, stenosis on Ultrasound = 80 ± 9% vs. 11 asymptomatic patients, median
age 60, stenosis = 83 ± 9%). C) ROC curve analysis showed that T2 mapping had a fair/good ability to discriminate between symptomatic and
asymptomatic plaques (AUC = 0.79, P = 0.012). The optimal cut-off value for lipid area was ~25% (sensitivity = 67%, specificity = 91%).
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9 patients was excellent: ICC = 0.89 (95% CI 0.59-0.98)
and CoV = 8.9%.
Conclusions
We have demonstrated that carotid T2 mapping can be
used to quantify plaque lipid content with good accu-
racy and reproducibility, and to classify plaques as
symptomatic or asymptomatic based on their lipid core
size. This technique can potentially be used to identify
patients at risk of plaque rupture; informing decisions of
stents vs. surgery; stratify for more intensive lipid treat-
ment; and monitor response to treatment in clinical
trials.
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